We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 0HF9 market cap is 4.71B. The company's latest EPS is USD -0.1878 and P/E is -47.12.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 260.89M | 305.51M | 329.23M | 399.36M | 528.3M |
| Operating Income | -247M | -206.43M | -204.43M | -73.49M | 24.88M |
| Net Income | -276.85M | -250.46M | -236.57M | -151.58M | -56.11M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 886.52M | 905.14M | 724.17M | 777.88M | 785.03M |
| Total Liabilities | 600.14M | 597.77M | 601.12M | 617.71M | 590.99M |
| Total Equity | 286.38M | 307.37M | 123.05M | 160.17M | 194.05M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -233.29M | -202.49M | -166.58M | -69.09M | -33.89M |
| Investing | -13.58M | 78.76M | 92.32M | 98.06M | -560k |
| Financing | 262.86M | 212.07M | -7.46M | 61.68M | 5.12M |
| Market Cap | 4.71B |
| Price to Earnings Ratio | -47.12 |
| Price to Sales Ratio | 5.01 |
| Price to Cash Ratio | 12.37 |
| Price to Book Ratio | 13.63 |
| Dividend Yield | - |
| Shares Outstanding | 298.81M |
| Average Volume (1 week) | 495 |
| Average Volume (1 Month) | 711 |
| 52 Week Change | 0.00% |
| 52 Week High | 15.75 |
| 52 Week Low | 15.75 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Amicus Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.amicusrx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
